The 3-, 5- and 8-year estimates for recurrence in TNBC.
收藏数据链接：
官方服务：
资源简介：
The 3-, 5- and 8-year estimates for recurrence in TNBC.
应用场景：
创建时间：
2015-12-02
相关数据集
Additional file 10 of Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer
Supplementary Tables
DataCite Commons2024-08-18 更新90
Metadata supporting data files of the related article: Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification
The study sought to refine the Oncotype DX risk score by metabolomics analysis of serum derived from patients with early breast cancer (eBC). The analytical technique used to perform the metabolomics
NIAID Data Ecosystem10
Table 3_Pathological complete response and prognostic predictive factors of neoadjuvant chemoimmunotherapy in early stage triple-negative breast cancer.docx
BackgroundNeoadjuvant chemoimmunotherapy (nCIT) has shown promise in treating early-stage triple-negative breast cancer (eTNBC), but predictive biomarkers for pathological response and prognosis remai
NIAID Data Ecosystem00
Table_6_A Five-Gene-Pair-Based Prognostic Signature for Predicting the Relapse Risk of Early Stage ER+ Breast Cancer.XLSX
About 20–30% of early-stage breast cancer patients suffer relapses after surgery. To identify such high-risk patients, many signatures have been reported, but they lack robustness in data measured on
NIAID Data Ecosystem20
DataSheet_3_Natural killer cell-related prognostic risk model predicts prognosis and treatment outcomes in triple-negative breast cancer.pdf
BackgroundNatural killer (NK) cells are crucial to the emergence, identification, and prognosis of cancers. The roles of NK cell-related genes in the tumor immune microenvironment (TIME) and immunothe
NIAID Data Ecosystem10
